Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Adenovirus early E4 genes in viral oncogenesis

Abstract

Previous investigations into potential transforming activities of adenovirus (Ad) early genes were largely overshadowed by the more obvious roles of E1A and E1B products. One exception was an Ad9 E4 protein (ORF1) shown to enhance transformation of cultured cells and promote mammary tumors in female rats. Recently, significant advances in understanding Ad E4 gene products at the molecular level have revealed that these proteins possess an unexpectedly diverse collection of functions, which not only orchestrate many viral processes, but overlap with oncogenic transformation of primary mammalian cells. Operating through a complex network of protein interactions with key viral and cellular regulatory components, Ad E4 products are apparently involved in transcription, apoptosis, cell cycle control, DNA repair, cell signaling, posttranslational modifications and the integrity of nuclear multiprotein complexes known as PML oncogenic domains (PODs). Some of these functions directly relate to known transforming and oncogenic processes, or implicate mechanisms such as modulating the function and subcellular localization of cellular PDZ domain-containing proteins, POD reorganization, targeted proteolytic degradation, inhibition of DNA double-strand break repair and ‘hit-and-run’ mutagenesis. Here, we summarize the recent data and discuss how E4 gene product interactions may contribute to viral oncogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Ankerst J, Jonsson N . 1989 J. Natl. Cancer Inst. 81: 294–298

  • Ankerst J, Jonsson N, Kjellen L, Norrby E, Sjogren HO . 1974 Int. J. Cancer 13: 286–290

  • Bernards R, de Leeuw MG, Vaessen MJ, Houweling A, van der Eb AJ . 1984 J. Virol. 50: 847–853

  • Boyer JL, Ketner G . 2000 J. Biol. Chem. 275: 14969–14978

  • Boyer JL, Rohleder K, Ketner G . 1999 Virology 263: 307–312

  • Brackmann KH, Green M, Wold WS, Cartas M, Matsuo T, Hashimoto S . 1980 J. Biol. Chem. 255: 6772–6779

  • Bridge E, Ketner G . 1989 J. Virol. 63: 631–638

  • Bridge E, Ketner G . 1990 Virology 174: 345–353

  • Carvalho T, Seeler JS, Öhman K, Jordan P, Pettersson U, Akusjärvi G, Carmo Fonseca M, Dejean A . 1995 J. Cell. Biol. 131: 45–56

  • Cathomen T, Weitzman MD . 2000 J. Virol. 74: 11407–11412

  • Cress WD, Nevins JR . 1996a Mol. Cell. Biol. 16: 2119–2127

  • Cress WD, Nevins JR . 1996b Curr. Top. Microbiol. Immunol. 208: 63–78

  • Cutt JR, Shenk T, Hearing P . 1987 J. Virol. 61: 543–552

  • Dix I, Leppard KN . 1995 J. Gen. Virol. 76: 1051–1055

  • Dobbelstein M, Roth J, Kimberly WT, Levine AJ, Shenk T . 1997 EMBO J. 16: 4276–4284

  • Dobner T, Horikoshi N, Rubenwolf S, Shenk T . 1996 Science 272: 1470–1473

  • Dobner T, Kzhyshkowska J . 2001 Curr. Top. Microbiol. Immunol. 259: 25–54

  • Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG . 1996 Genes Dev. 10: 196–207

  • Downey JF, Rowe DT, Bacchetti S, Graham FL, Bayley ST . 1983 J. Virol. 45: 514–523

  • Esche H . 1982 J. Virol. 41: 1076–1082

  • Esche H, Schilling R, Dörfler W . 1979 J. Virol. 30: 21–31

  • Esche H, Siegman B . 1982 J. Gen. Virol. 60: 99–113

  • Fanning AS, Anderson JM . 1999 J. Clin. Invest. 103: 767–772

  • Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561

  • Flint SJ, Gallimore PH, Sharp PA . 1975 J. Mol. Biol. 96: 47–68

  • Flint SJ, Sambrook J, Williams JF, Sharp PA . 1976 Virology 72: 456–470

  • Flint SJ, Sharp PA . 1976 J. Mol. Biol. 106: 749–771

  • Freyer GA, Katoh Y, Roberts RJ . 1984 Nucl. Acids Res. 12: 3503–3519

  • Gardiol D, Kuhne C, Glaunsinger BA, Lee SS, Javier RT, Banks L . 1999 Oncogene 18: 5487–5496

  • Glaunsinger BA, Lee SS, Thomas M, Banks L, Javier RT . 2000 Oncogene 19: 5270–5280

  • Goodrum FD, Ornelles DA . 1999 J. Virol. 73: 7474–7488

  • Goodrum FD, Shenk T, Ornelles DA . 1996 J. Virol. 70: 6323–6335

  • Graham FL . 1984 The adenoviruses. Ginsberg HS (ed) Plenum Press: New York pp 339–398

  • Grand RJ, Grant ML, Gallimore PH . 1994 Virology 203: 229–240

  • Grifman M, Chen NN, Gao G, Cathomen T, Wilson JM, Weitzman MD . 1999 J. Virol. 73: 10010–10019

  • Halbert DN, Cutt JR, Shenk T . 1985 J. Virol. 56: 250–257

  • Hardy S, Engel DA, Shenk T . 1989 Genes Dev. 3: 1062–1074

  • Hardy S, Shenk T . 1989 Mol. Cell. Biol. 9: 4495–4506

  • Herisse J, Rigolet M, de Dinechin SD, Galibert F . 1981 Nucl. Acids Res. 9: 4023–4042

  • Horwitz MS . 1996 Virology Vol. 2. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven: New York pp 2149–2171

    Google Scholar 

  • Huang MM, Hearing P . 1989a J. Virol. 63: 2605–2615

  • Huang MM, Hearing P . 1989b Genes Dev. 3: 1699–1710

  • Javier RT . 1994 J. Virol. 68: 3917–3924

  • Javier RT, Raska Jr K, Macdonald GJ, Shenk T . 1991 J. Virol. 65: 3192–3202

  • Javier RT, Raska Jr K, Shenk T . 1992 Science 257: 1267–1271

  • Javier RT, Shenk T . 1996 Breast Cancer Res. Treatment 39: 57–67

  • Johnson DG, Cress WD, Jakoi L, Nevins JR . 1994 Proc. Natl. Acad. Sci. USA 91: 12823–12827

  • Jonsson N, Ankerst J . 1977 Cancer 39: 2513–2519

  • Kleinberger T . 2000 Apoptosis 5: 211–215

  • Kleinberger T, Shenk T . 1993 J. Virol. 67: 7556–7560

  • König C, Roth J, Dobbelstein M . 1999 J. Virol. 73: 2253–2262

  • Kovesdi I, Reichel R, Nevins JR . 1986a Science 231: 719–722

  • Kovesdi I, Reichel R, Nevins JR . 1986b Cell 45: 219–228

  • Kovesdi I, Reichel R, Nevins JR . 1987 Proc. Natl. Acad. Sci. USA 84: 2180–2184

  • Lee SS, Glaunsinger BA, Mantovani F, Banks L, Javier RT . 2000 J. Virol. 74: 9680–9693

  • Lee SS, Weiss RS, Javier RT . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675

  • Leppard KN, Everett RD . 1999 J. Gen. Virol. 80: 997–1008

  • Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM . 1999 Proc. Natl. Acad. Sci. USA 96: 11364–11369

  • Marton MJ, Baim SB, Ornelles DA, Shenk T . 1990 J. Virol. 64: 2345–2359

  • Moore M, Horikoshi N, Shenk T . 1996 Proc. Natl. Acad. Sci. USA 93: 11295–11301

  • Neill SD, Hemstrom C, Virtanen A, Nevins JR . 1990 Proc. Natl. Acad. Sci. USA 87: 2008–2012

  • Neill SD, Nevins JR . 1991 J. Virol. 65: 5364–5373

  • Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T . 1997 Proc. Natl. Acad. Sci. USA 94: 1206–1211

  • Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T . 2000 J. Virol. 74: 5168–5181

  • Nevels M, Spruss T, Wolf H, Dobner T . 1999a Oncogene 18: 9–17

  • Nevels M, Täuber B, Kremmer E, Spruss T, Wolf H, Dobner T . 1999b J. Virol. 73: 1591–1600

  • Nevels M, Täuber B, Spruss T, Wolf H, Dobner T . 2001 J. Virol. 75: 3089–3094

  • Nevins JR, Vogt PK . 1996 Virology Vol. 1: Fields Virology. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven: New York pp 301–343

    Google Scholar 

  • Nicolás AL, Munz PL, Falck-Pedersen E, Young CSH . 2000 Virology 266: 211–224

  • O'Connor RJ, Hearing P . 1991 Nucl. Acids Res. 19: 6579–6586

  • O'Connor RJ, Hearing P . 2000 J. Virol. 74: 5819–5824

  • Obert S, O'Connor RJ, Schmid S, Hearing P . 1994 Mol. Cell. Biol. 14: 1333–1346

  • Öhman K, Nordquist K, Linder S, Akusjärvi G . 1995 Int. J. Oncol. 6: 663–668

  • Orlando JS, Ornelles DA . 1999 J. Virol. 73: 4600–4610

  • Ornelles DA, Shenk T . 1991 J. Virol. 65: 424–429

  • Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E, de The H . 1995 Exp. Cell. Res. 218: 9–16

  • Querido E, Marcellus RC, Lai A, Rachel C, Teodoro JG, Ketner G, Branton PE . 1997 J. Virol. 71: 3788–3798

  • Querido E, Morisson MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE . 2001 J. Virol. 75: 699–709

  • Raychaudhuri P, Bagchi S, Nevins JR . 1989 Genes Dev. 3: 620–627

  • Reichel R, Neill SD, Kovesdi I, Simon MC, Raychaudhuri P, Nevins JR . 1989 J. Virol. 63: 3643–3650

  • Roth J, König C, Wienzek S, Weigel S, Ristea S, Dobbelstein M . 1998 J. Virol. 72: 8510–8516

  • Sarnow P, Hearing P, Anderson CW, Halbert DN, Shenk T, Levine AJ . 1984 J. Virol. 49: 692–700

  • Sarnow P, Hearing P, Anderson CW, Reich N, Levine AJ . 1982 J. Mol. Biol. 162: 565–583

  • Schaley J, O'Connor RJ, Taylor LJ, Bar-Sagi D, Hearing P . 2000 J. Virol. 74: 2084–2093

  • Shiroki K, Hashimoto S, Saito I, Fukui Y, Kato H, Shimojo H . 1984 J. Virol. 50: 854–863

  • Singh P, Wong SH, Hong W . 1994 EMBO J. 13: 3329–3338

  • Smith GCM, Jackson SP . 1999 Genes Dev. 13: 916–934

  • Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL . 1998 Oncogene 16: 349–357

  • Täuber B, Dobner T . 2001 Gene in press

  • Terris B, Baldin V, Dubois S, Degott C, Flejou J-F, Hénin D, Dejean A . 1995 Cancer Res. 55: 1590–1597

  • Thomas DL, Schaack J, Vogel H, Javier RT . 2001 J. Virol. 75: 557–568

  • Thomas DL, Shin S, Jiang BH, Vogel H, Ross MA, Kaplitt M, Shenk TE, Javier RT . 1999 J. Virol. 73: 3071–3079

  • Trentin JJ, Yabe Y, Taylor G . 1962 Science 137: 835–849

  • Virtanen A, Gilardi P, Naslund A, LeMoullec JM, Pettersson U, Perricaudet M . 1984 J. Virol. 51: 822–831

  • Weiden MD, Ginsberg HS . 1994 Proc. Natl. Acad. Sci. USA 91: 153–157

  • Weiss RS, Javier RT . 1997 J. Virol. 71: 7873–7880

  • Weiss RS, Gold MO, Vogel H, Javier RT . 1997a J. Virol. 71: 4385–4394

  • Weiss RS, Lee SS, Prasad BV, Javier RT . 1997b J. Virol. 71: 1857–1870

  • Weiss RS, McArthur MJ, Javier RT . 1996 J. Virol. 70: 862–872

  • Wienzek S, Dobbelstein M . 2001 J. Virol. 75: 5391–5397

  • Wienzek S, Roth J, Dobbelstein M . 2000 J. Virol. 74: 193–202

  • Xu G, Livingston DM, Krek W . 1995 Proc. Natl. Acad. Sci. USA 92: 1357–1361

  • Yamano S, Tokino T, Yasuda M, Kaneuchi M, Takahashi M, Niitsu Y, Fujinaga K, Yamashita T . 1999 J. Virol. 73: 10095–10103

  • Zalmanzon ES . 1987 Eksp. Onkol. 9: 3–8

  • Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y . 1998 Nature 396: 373–376

  • Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP . 1999 Oncogene 18: 7941–7947

Download references

Acknowledgements

We are most grateful to Avril Arthur for critically reading the manuscript and Phil Branton for providing unpublished information. Work in this laboratory was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and from the Fonds der Chemischen Industrie (FCI) to T Dobner.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Dobner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Täuber, B., Dobner, T. Adenovirus early E4 genes in viral oncogenesis. Oncogene 20, 7847–7854 (2001). https://doi.org/10.1038/sj.onc.1204914

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204914

Keywords

This article is cited by

Search

Quick links